http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#Head http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#assertion http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#provenance http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#pubinfo http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#assertion http://purl.obolibrary.org/obo/DOID_10456 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_10456 http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01416 http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#association http://www.w3.org/2000/01/rdf-schema#label cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below recommended dosages durations of therapy and applicable patient populations vary among these infections please see dosage and administration acute otitis media streptococcus pneumoniae streptococcus pyogenes haemophilus influenzae moraxella branhamella catarrhalis pharyngitis and or tonsillitis streptococcus pyogenes note community acquired pneumonia s pneumoniae h influenzae acute bacterial exacerbation of chronic bronchitis s pneumoniae h influenzae m catarrhalis h influenzae acute uncomplicated urethral and cervical gonorrhea neisseria gonorrhoeae acute uncomplicated ano rectal infections in women neisseria gonorrhoeae note n gonorrhoeae n gonorrhoeae uncomplicated skin and skin structure infections staphylococcus aureus streptococcus pyogenes note dosage and administration acute maxillary sinusitis haemophilus influenzae streptococcus pneumoniae moraxella catarrhalis uncomplicated urinary tract infections cystitis escherichia coli klebsiella pneumoniae proteus mirabilis staphylococcus saprophyticus note clinical studies appropriate specimens for bacteriological examination should be obtained in order to isolate and identify causative organisms and to determine their susceptibility to cefpodoxime therapy may be instituted while awaiting the results of these studies once these results become available antimicrobial therapy should be adjusted accordingly to reduce the development of drug resistant bacteria and maintain the effectiveness of cefpodoxime proxetil for oral suspension usp and other antibacterial drugs cefpodoxime proxetil for oral suspension usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB01416 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#provenance http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#pubinfo http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#sig http://purl.org/nanopub/x/hasSignature UxbCzkPYE2CHIX3nRGgjRSYlAxDsXQI4/lCvhfosz1BmGDPoYMgS73M3uoR0987vd6Dmv8c/QFQWiMPEEnPCDr8PvtR72prNMsbx4/yzh2TlZup2A7ryHp07cTHdTVLMZDD11ME8NirLrV9y/OLUi1GiBdcig2kSOPRfU+7ioJw= http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA http://purl.org/dc/terms/created 2021-06-27T20:02:36.372+02:00 http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA0J1laNpN0TO5IkmfBnbYKSIt4kFw95W0_2PRlpO4TAA https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs